T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Southside Bancshares
SBSI
$984M
| $609K | ﹤0.01% |
15,900
-4,000
| -20% | -$147K |
|
|
OSG
2277
Octave Specialty Group
OSG
$212M
| $608K | ﹤0.01% |
42,474
+233
| +0.6% | +$3.33K |
|
2278
Fulgent Genetics
FLGT
$513M
| $608K | ﹤0.01% |
6,755
-2
| -0% | -$182 |
|
|
PR
2279
Permian Resources
PR
$17.7B
| $608K | ﹤0.01% |
90,776
+33,900
| +60% | +$185K |
|
2280
Hingham Institution for Saving
HIFS
$686M
| $606K | ﹤0.01% |
1,800
-111
| -6% | -$34.7K |
|
2281
Forward Air
FWRD
$682M
| $605K | ﹤0.01% |
7,290
-282
| -4% | -$24.7K |
|
2282
Community Health Systems
CYH
$419M
| $604K | ﹤0.01% |
51,588
-4,900
| -9% | -$63.9K |
|
|
PRPC.U
2283
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
| $603K | ﹤0.01% |
60,625
+23,571
| +64% | +$235K |
|
|
DMC
2284
Del Monte Corp
DMC
$1.44B
| $600K | ﹤0.01% |
18,624
-84
| -0.4% | -$2.65K |
|
|
ACRE
2285
Ares Commercial Real Estate
ACRE
$264M
| $598K | ﹤0.01% |
39,669
-11,780
| -23% | -$179K |
|
|
HMHC
2286
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $597K | ﹤0.01% |
44,468
+8,913
| +25% | +$112K |
|
2287
Gevo
GEVO
$401M
| $596K | ﹤0.01% |
89,710
-7,545
| -8% | -$46.7K |
|
2288
SandRidge Energy
SD
$516M
| $595K | ﹤0.01% |
45,700
-16,400
| -26% | -$136K |
|
2289
Teck Resources
TECK
$31.3B
| $593K | ﹤0.01% |
23,811
-169
| -0.7% | -$3.87K |
|
2290
Beazer Homes USA
BZH
$874M
| $591K | ﹤0.01% |
34,238
| – | – |
|
2291
Dyne Therapeutics
DYN
$4.85B
| $590K | ﹤0.01% |
+36,358
| New | +$645K |
|
2292
Aclaris Therapeutics
ACRS
$863M
| $589K | ﹤0.01% |
32,742
-9,235
| -22% | -$148K |
|
|
UBA
2293
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $588K | ﹤0.01% |
31,052
| – | – |
|
2294
PBF Energy
PBF
$8.81B
| $587K | ﹤0.01% |
45,274
+12,880
| +40% | +$134K |
|
|
MGLN
2295
DELISTED
Magellan Health Services, Inc.
MGLN
| $587K | ﹤0.01% |
6,204
-371
| -6% | -$35.1K |
|
2296
iShares Biotechnology ETF
IBB
$9.77B
| $584K | ﹤0.01% |
3,614
| – | – |
|
2297
Blink Charging
BLNK
$87.1M
| $583K | ﹤0.01% |
20,390
+900
| +5% | +$29.2K |
|
2298
Genesco
GCO
$394M
| $579K | ﹤0.01% |
10,035
-2,600
| -21% | -$155K |
|
2299
nLIGHT
LASR
$2.9B
| $577K | ﹤0.01% |
20,483
+9,089
| +80% | +$270K |
|
2300
Tejon Ranch
TRC
$443M
| $576K | ﹤0.01% |
32,421
-6,600
| -17% | -$117K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.